Lundbeck Foundation
Christian E. Elling heads the early-stage biotech investment unit Lundbeckfonden BioCapital.
He is a member of the board of directors of IO Biotech, NMD Pharma, Afyx Therapeutics, SNIPR Biome, Folium and a former member of the board of directors of EpiTherapeutics and Inagen.
Christian was previously co-founder, Vice President of Biology and Development, and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his Ph.D. in pharmacology from the University of Copenhagen, Denmark.
This person is not in any offices
Lundbeck Foundation
The Lundbeck Foundation is an active industrial Foundation. They fund biomedical sciences research – and they have a special fondness for the brain. They invest responsibly, sustainably and with a long-term perspective, focusing in particular on healthcare enterprises. All of their activities focus on improving lives and steering society in a healthier direction. Their ambition is for Denmark to become a leading research nation, with a flourishing business sector in the field of healthcare and offering exemplary diagnosis and treatment of patients with brain disorders.